PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

NCT06758024 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Disease (IBD)
Crohn Disease (CD)
Ulcerative Colitis (UC)

Interventions

DRUG: Infliximab
DRUG: Infliximab

Sponsor

Pontificia Universidad Catolica de Chile

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]